Skip to main content

The evidence behind our claims

At Biomin, we only make claims we can back with clinical evidence. This page explains what our claims mean and the clinical studies behind them.

Claim 1

“No other sensitivity toothpaste is proven more effective.”*

*with 4 weeks twice-daily brushing.

BioMin® F Sensitivity has been tested directly against the main categories of sensitivity toothpastes in 11 clinical studies listed in the below references. In every study, by 4 weeks of use onwards, BioMin F Sensitivity was as effective as or more effective than the toothpaste it was compared with.

Claim 2

“Clinically proven to reduce sensitivity pain by up to 90%.”*

*with 4 weeks twice-daily brushing.

In a randomised clinical trial of 75 adults with sensitive teeth, people using BioMin ® F Sensitivity had an average 90.9% reduction in sensitivity pain after 1 month. That was significantly more than people using an arginine sensitivity toothpaste (56%) or a placebo toothpaste (23%). Pain was scored from 0 to 10 when a short puff of air was applied to the sensitive tooth. Results vary from person to person(7).

References

These are all 11 clinical studies that have compared BioMin ® F Sensitivity directly with other toothpastes. Some were carried out in India under local brand names, Elsenz and Hydent Pro.

1. Aggarwal SD, Borkar A, Borse N, Acharya A. Comparative evaluation of fluoro calcium phosphosilicate, calcium sodium phosphosilicate, and strontium chloride hexahydrate containing dentifrice for the treatment of dentin hypersensitivity: a randomized single-blind study. J Int Oral Health 2019;11(6):404–11. doi:10.4103/jioh.jioh_228_19
2. Arshad S, Zaidi SJA, Farooqui WA. Comparative efficacy of BioMin-F, Colgate Sensitive Pro-relief and Sensodyne Rapid Action in relieving dentin hypersensitivity: a randomized controlled trial. BMC Oral Health 2021;21:498. doi:10.1186/s12903-021-01864-x
3. Ashwini S, Swatika K, Kamala DN. Comparative evaluation of desensitizing efficacy of dentifrice containing 5% fluoro calcium phosphosilicate versus 5% calcium sodium phosphosilicate: a randomized controlled clinical trial. Contemp Clin Dent 2018;9(3):330–6.
4. Bhatt V, Prabhu A, Mehta R, Pillai M, Bhakk S, Agarwal S. Efficacy of a fluoro-calcium phosphosilicate dentifrice (Elsenz®) as compared to a potassium nitrate dentifrice in the treatment of dentinal hypersensitivity: a randomized controlled study. Int J Recent Sci Res 2019;10(5A):32162–7. doi:10.24327/ijrsr.2019.1005.3410
5. Gautam V, Halwai HK. Comparison of clinical efficacy of four dentifrices in the management of dentinal hypersensitivity. Int J Sci Res 2017;6(2):239–40.
6. Hussain H, Jan SM, Behal R. Clinical comparison of 5% fluoro calcium phosphosilicate versus 5% calcium sodium phosphosilicate in the treatment of dentinal hypersensitivity. Int J Med Biomed Stud 2019;3(5):146–50. doi:10.32553/ijmbs.v3i5.254
7. Patel VR, Shettar L, Thakur S, Gillam D, Kamala DN. A randomised clinical trial on the efficacy of 5% fluorocalcium phosphosilicate-containing novel bioactive glass toothpaste. J Oral Rehabil 2019;46(12):1121–6. doi:10.1111/joor.12847
8. Prathyusha G, Anusha G, Amruthavalli MYSLNV, Sri PSS, Keerthi NS. Comparative evaluation of the efficacy of commercially available fluoro-calcium phospho-silicate with sodium monofluorophosphate in reducing dentinal hypersensitivity: a randomized controlled trial. J Dr YSR Univ Health Sci 2024;13(4):330–6. doi:10.4103/jdrysruhs.jdrysruhs_157_23
9. Prithyani SS, Mitra DK, Talati MA, Donde RJ, Shah RA, Rodrigues SV, Shetty GP, Vijayakar HN. Treating the twinge – BIOMIN. Acta Sci Dent Sci 2019;3(1):45–9.
10. Reddy GV, Surakanti JR, Vemisetty H, Doranala S, Hanumanpally JR, Malgikar S. Comparative assessment of effectiveness of Biomin, NovaMin, herbal, and potassium nitrate desensitizing agents in the treatment of hypersensitive teeth: a clinical study. J Dr NTR Univ Health Sci 2019;8(1):24.
11. Shrimathi S. Effect of BioMinF, NovaminR, Argin and nanohydroxy particles containing dentifrices on dentine hypersensitivity and gingivitis among 35–44 years aged population of Madurai district: a randomized controlled trial. MDS dissertation, Best Dental Science College, Madurai, 2020.